Skip to content
  • 2019 CATALOG
  • NEWSROOM
    • Latest News
    • Publications
    • Press Releases
    • Videos
    • Posters
    • Events
  • CONTACT
    • General Inquiries
    • Customer Support
    • Technical Support
    • Global Distributor Support
  • LabPMM
    • LabPMM, LLC (USA)
    • LabPMM, GmbH (Germany)
    • LabPMM, GK (Japan)
  • MY ACCOUNT
    • Login
    • Create Account
Invivoscribe Logo Invivoscribe Logo Invivoscribe Logo
  • PRODUCTS
    • Products Overview

      Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

      EXPLORE PRODUCTS ⟶
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
      • Companion Diagnostics
    • Gel Detection
      • CE-IVD
        • Clonality
        • FLT3
        • Translocations
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • Companion Diagnostics (CDx)
    • 2019 Product Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview

      The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

      EXPLORE SERVICES ⟶
    • NGS Cancer Panels
      • MyMRD
      • MyAML
      • MyHEME
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Targeted Genes
      • FLT3
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • Custom Assays
    • 2019 Services Catalog
  • DISEASES
    • Lymphoid
      • Mature B-cell
      • Mature T-cell
    • Myeloid
      • Myelodysplastic Syndromes (MDS)
      • Acute Myeloid Leukemia (AML)
      • Myeloproliferative Neoplasms (MPNs)
    • Hematological Testing Menu

      Browse our comprehensive menu of product & testing services.

      EXPLORE MENU ⟶
  • PARTNERSHIPS
    • Partnerships Overview

      A proven strategy to accelerate
      drug approvals

      EXPLORE PARTNERSHIPS ⟶
    • Product Development

      Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

      EXPLORE ⟶
    • Manufacturing

      cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

      EXPLORE ⟶
    • LabPMM®

      Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

      EXPLORE ⟶
    • Global Regulatory Expertise

      Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

      EXPLORE ⟶
  • SCIENCE
    • Science Overview

      We take pride in expanding the science that bridges personalized medicine with quality healthcare.

      EXPLORE OUR SCIENCE ⟶
    • Personalized Medicine

      Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

      EXPLORE PERSONALIZED MEDICINE ⟶
  • PUBLICATIONS
    • Featured Publication

      March 21st, 2019
      Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms

      VIEW PUBLICATION ⟶
    • Latest Publications

      August 25th, 2018
      A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations

      VIEW PUBLICATION ⟶

      August 22nd, 2018
      Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL

      VIEW PUBLICATION ⟶
      VIEW ALL PUBLICATIONS ⟶
  • COMPANY
    • Company
      • About Us
      • Leadership Team
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Search Career Openings
    • Invivoscribe Locations
       
      Invivoscribe, Inc. (USA)
      San Diego, CA, US
      CONTACT US ⟶
       
      Invivoscribe, SARL (France)
      La Ciotat, France
      CONTACT US ⟶
       
      Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
      Shanghai, China
      CONTACT US ⟶
    • LabPMM Locations
       
      LabPMM, LLC (USA)
      San Diego, CA, US
      CONTACT US ⟶
       
      LabPMM, GmbH (Germany)
      Martinsried, Germany
      CONTACT US ⟶
       
      LabPMM, GK (Japan)
      Kanagawa 210-0821, Japan
      CONTACT US ⟶
    • Support
       
      Invivoscribe, Inc. (USA)
      CONTACT US ⟶
       
      Invivoscribe, SARL (France)
      CONTACT US ⟶
       
      Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
      CONTACT US ⟶
       
      LabPMM, LLC (USA)
      CONTACT US ⟶
       
      LabPMM, GmbH (Germany)
      CONTACT US ⟶
       
      LabPMM, GK (Japan)
      CONTACT US ⟶
  • Search
    • Search Articles & Publications
    • Search Product & Service Catalog
      CATALOG SEARCH ⟶
Next-Generation Sequencingadmin2019-07-18T22:57:04+00:00
  • PRODUCTS
    • Products Overview
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
      • Companion Diagnostics
    • Gel Detection
      • CE-IVD
        • Clonality
        • FLT3
        • Translocations
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • Companion Diagnostics (CDx)
    • 2019 Product Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview
    • NGS Cancer Panels
      • MyMRD
      • MyAML
      • MyHEME
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Targeted Genes
      • FLT3
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • Custom Assays
    • 2019 Services Catalog
  • DISEASES
    • Lymphoid
      • Mature B-cell
      • Mature T-cell
    • Myeloid
      • Myelodysplastic Syndromes (MDS)
      • Acute Myeloid Leukemia (AML)
      • Myeloproliferative Neoplasms (MPNs)
    • Hematological Testing Menu
  • PARTNERSHIPS
    • Partnerships Overview
    • Product Development
    • Manufacturing
    • LabPMM®
    • Global Regulatory Expertise
  • SCIENCE
    • Science Overview
    • Personalized Medicine
  • PUBLICATIONS
    • Featured Publication
    • Latest Publications
  • COMPANY
    • Company
      • About Us
      • Leadership Team
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Search Career Openings
    • Invivoscribe Locations
    • LabPMM Locations
    • Support
  • Search
    • Search Articles & Publications
    • Search Product & Service Catalog

INVIVOSCRIBE

 
Invivoscribe, Inc. (USA)
San Diego, CA, US
CONTACT US ⟶
 
Invivoscribe, SARL (France)
La Ciotat, France
CONTACT US ⟶
 
Invivoscribe Diagnostic Technologies, (Shanghai) Co., Ltd.
Shanghai, China
CONTACT US ⟶

LabPMM

 
LabPMM, LLC (USA)
San Diego, CA, US
CONTACT US ⟶
 
LabPMM, GmbH (Germany)
Martinsried, Germany
CONTACT US ⟶
 
LabPMM, GK (Japan)
Kanagawa 210-0821, Japan
CONTACT US ⟶

PRIVACY/TERMS & CONDITIONS

Terms and Conditions
Web Privacy Policy
Privacy Shield Policy
Licensure and Certifications
Global Distributors

CONNECT

© 2018 -    |   Invivoscribe, Inc. |   All Rights Reserved

Global Search

SEARCH BY KEYWORD

Global Search

SEARCH BY KEYWORD

Looking for Product Documents?
Try our New Document Search Feature ⟶

Looking for Product Documents?
Try our New Document Search Feature ⟶

We use cookies to improve your experience and our website service. To read about our cookies policy, please read our privacy statement. By continuing to browse our site, you accept our use of cookies.

Accept and Continue

We use cookies to improve your experience and our website service.
To read about our cookies policy, please read our privacy statement.
By continuing to browse our site, you accept our use of cookies.

Accept and Continue
  • PRODUCTS
    • Products Overview
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
      • Companion Diagnostics
    • Gel Detection
      • CE-IVD
        • Clonality
        • FLT3
        • Translocations
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • Companion Diagnostics (CDx)
    • 2019 Product Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview
    • NGS Cancer Panels
      • MyMRD
      • MyAML
      • MyHEME
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Targeted Genes
      • FLT3
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • Custom Assays
    • 2019 Services Catalog
  • DISEASES
    • Lymphoid
      • Mature B-cell
      • Mature T-cell
    • Myeloid
      • Myelodysplastic Syndromes (MDS)
      • Acute Myeloid Leukemia (AML)
      • Myeloproliferative Neoplasms (MPNs)
    • Hematological Testing Menu
  • PARTNERSHIPS
    • Partnerships Overview
    • Product Development
    • Manufacturing
    • LabPMM®
    • Global Regulatory Expertise
  • SCIENCE
    • Science Overview
    • Personalized Medicine
  • PUBLICATIONS
    • Featured Publication
    • Latest Publications
  • NEWSROOM
    • Latest News
    • Publications
    • Press Releases
    • Videos
    • Posters
    • Events
  • COMPANY
    • Company
      • About Us
      • Leadership Team
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Search Career Openings
    • Invivoscribe Locations
      • Invivoscribe, Inc. (USA)
      • Invivoscribe, SARL (France)
      • Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
    • LabPMM Locations
      • LabPMM, LLC (USA)
      • LabPMM, GmbH (Germany)
      • LabPMM, GK (Japan)
    • Support
LATEST NEWS
European Commission Approves Astellas’ XOSPATA™ for Patients ⟶

CONNECT